全文获取类型
收费全文 | 23299篇 |
免费 | 1235篇 |
国内免费 | 255篇 |
专业分类
耳鼻咽喉 | 252篇 |
儿科学 | 506篇 |
妇产科学 | 684篇 |
基础医学 | 2661篇 |
口腔科学 | 525篇 |
临床医学 | 1718篇 |
内科学 | 6293篇 |
皮肤病学 | 412篇 |
神经病学 | 2518篇 |
特种医学 | 897篇 |
外科学 | 3722篇 |
综合类 | 48篇 |
一般理论 | 4篇 |
预防医学 | 903篇 |
眼科学 | 285篇 |
药学 | 1374篇 |
中国医学 | 49篇 |
肿瘤学 | 1938篇 |
出版年
2023年 | 170篇 |
2022年 | 339篇 |
2021年 | 721篇 |
2020年 | 448篇 |
2019年 | 531篇 |
2018年 | 703篇 |
2017年 | 568篇 |
2016年 | 654篇 |
2015年 | 727篇 |
2014年 | 939篇 |
2013年 | 1140篇 |
2012年 | 1791篇 |
2011年 | 1817篇 |
2010年 | 1023篇 |
2009年 | 1008篇 |
2008年 | 1634篇 |
2007年 | 1616篇 |
2006年 | 1478篇 |
2005年 | 1408篇 |
2004年 | 1372篇 |
2003年 | 1230篇 |
2002年 | 1083篇 |
2001年 | 166篇 |
2000年 | 134篇 |
1999年 | 182篇 |
1998年 | 189篇 |
1997年 | 173篇 |
1996年 | 172篇 |
1995年 | 130篇 |
1994年 | 90篇 |
1993年 | 96篇 |
1992年 | 101篇 |
1991年 | 75篇 |
1990年 | 70篇 |
1989年 | 86篇 |
1988年 | 58篇 |
1987年 | 72篇 |
1986年 | 58篇 |
1985年 | 43篇 |
1984年 | 59篇 |
1983年 | 53篇 |
1982年 | 38篇 |
1981年 | 42篇 |
1980年 | 42篇 |
1979年 | 25篇 |
1978年 | 20篇 |
1977年 | 24篇 |
1976年 | 18篇 |
1974年 | 18篇 |
1971年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs 总被引:12,自引:0,他引:12
Fiorucci S Antonelli E Distrutti E Rizzo G Mencarelli A Orlandi S Zanardo R Renga B Di Sante M Morelli A Cirino G Wallace JL 《Gastroenterology》2005,129(4):1210-1224
BACKGROUND & AIMS: Hydrogen sulfide (H(2)S), an endogenous gaseous mediator that causes vasodilation, is generated in mammalian tissues by cystathionine beta-synthase (CBS) and cystathionine-gamma-lyase (CSE). Here, we have investigated the role of H(2)S in a rodent model of nonsteroidal anti-inflammatory drug (NSAID) gastropathy. METHODS: Rats were given acetyl salycilic acid (ASA) or an NSAID alone or in combination with NaHS, an H(2)S donor, and killed 3 hours later. Gastric blood flow was measured by laser-Doppler flowmetry, whereas intravital microscopy was used to quantify adhesion of leukocytes to mesenteric postcapillary endothelium. RESULTS: At a dose of 100 micromol/kg, NaHS attenuated by 60%-70% the gastric mucosal injury, and tumor necrosis factor (TNF)-alpha, intercellular adhesion molecule (ICAM)-1, and lymphocyte function-associated antigen (LFA)-1 mRNA up-regulation induced by NSAIDs (P < .05) NaHS administration prevented the associated reduction of gastric mucosal blood flow (P < .05) and reduced ASA-induced leukocyte adherence in mesenteric venules. NaHS did not affect suppression of prostaglandin E(2) (PGE(2)) synthesis by NSAIDs. Glibenclamide, a K(ATP) channel inhibitor, and DL-propargylglycine, a CSE inhibitor, exacerbated, whereas pinacidil, a K(ATP) opener, attenuated gastric injury caused by ASA. Exposure to NSAIDs reduced H(2)S formation and CSE expression (mRNA and protein) and activity by 60%-70%. By promoter deletion and mutation analysis, an Sp1 consensus site was identified in the CSE promoter. Exposure to NSAIDs inhibits Sp1 binding to its promoter and abrogates CSE expression in HEK-293 cells transfected with a vector containing the core CSE promoter. Exposure to NSAIDs inhibits Sp1 and ERK phosphorylation. CONCLUSIONS: These data establish a physiologic role for H(2)S in regulating the gastric microcirculation and identify CSE as a novel target for ASA/NSAIDs. 相似文献
992.
Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohn's disease 总被引:2,自引:0,他引:2
Maconi G Di Sabatino A Ardizzone S Greco S Colombo E Russo A Cassinotti A Casini V Corazza GR Bianchi Porro G 《Scandinavian journal of gastroenterology》2005,40(11):1328-1333
OBJECTIVE: Reactive regional lymph node enlargement is a frequent ultrasonographic finding in patients with Crohn's disease. However, the prevalence of this condition and its clinical significance are unknown. This study assesses the prevalence of enlarged regional mesenteric lymph nodes and its clinical significance in Crohn's disease, and in particular whether there is a correlation between the sonographic detection of enlarged regional lymph nodes and the degree of clinical or biochemical activity of the disease. MATERIAL AND METHODS: A total of 240 in- and outpatients with Crohn's disease underwent intestinal ultrasound to assess the presence of enlarged regional lymph nodes as well as the thickness and echopattern of the bowel wall, the site and extent of Crohn's disease and the presence of stenosis, fistulas and abscesses. Demographic, clinical and biochemical parameters were also collected for each patient. A multivariate model by means of multiple regression analysis was used to identify independent variables linked to regional lymph node enlargement. RESULTS: Enlarged regional lymph nodes were detected ultrasonographically in 25.4% of Crohn's disease patients. The presence of regional lymph nodes showed a weak correlation with both clinical and biochemical Crohn's disease activity. Regional lymph nodes were found more frequently in young patients (50% of patients < 30 years, 18% of patients between 30 and 50 yrs, and 7% of patients > 50 yrs; p<0.0001) and in patients with a shorter disease duration. Enlarged regional lymph nodes were strongly correlated with internal fistulas and intra-abdominal abscesses. The multiple regression analysis showed that age, duration of disease and presence of internal fistulas were the best independent predictive factors linked to the presence of enlarged mesenteric lymph nodes. CONCLUSIONS: The sonographic detection of enlarged regional lymph nodes is more frequent in young patients, which suggests an earlier phase of Crohn's disease and the presence of septic complications such as fistulas and abscesses, but this is of limited valued in assessing disease activity. 相似文献
993.
Arca M Montali A Pigna G Antonini R Antonini TM Luigi P Fraioli A Mastrantoni M Maddaloni M Letizia C 《Metabolism: clinical and experimental》2007,56(11):1534-1541
Statins and fibrates have different effects on lipid abnormalities of familial combined hyperlipidemia (FCHL); thus, the selection of the first-line drug is troublesome. We evaluated to what extent monotherapy with a potent statin is more effective than fibrate in reaching the recommended lipid targets in FCHL. Fifty-six patients were randomized to receive optimal dosage of atorvastatin (n = 27) or 200 mg/d micronized fenofibrate (n = 29) for 24 weeks. To reach the optimal dosage, atorvastatin was up-titrated at each follow-up visit if low-density lipoprotein (LDL) cholesterol >130 mg/dL (>100 mg/dL in patients with coronary or cerebrovascular disease). The effects of fenofibrate and atorvastatin on lipoprotein fractions as well as on plasma levels of endothelin-1 (ET-1) and adrenomedullin (AM) were also evaluated. At end of trial, a greater proportion of patients on atorvastatin (average dosage, 20.8 mg/d) reached lipid targets in comparison with those on fenofibrate (64% vs 32.1%, P = .02). Atorvastatin was significantly more effective in reducing total cholesterol, LDL cholesterol, apolipoprotein B, and non-high-density lipoprotein (HDL) cholesterol. Conversely, triglycerides decreased and HDL increased more during fenofibrate. Nevertheless, atorvastatin produced a marked reduction in very low-density lipoprotein and very low-density lipoprotein remnants. Atorvastatin lowered all LDL subtypes, although fenofibrate appeared to be more effective on denser LDL. Compared with 43 normolipemic controls, FCHL patients presented increased baseline plasma levels of ET-1 (P = .007) but not of AM. Fenofibrate, but not atorvastatin, significantly lowered ET-1 levels by 16.7% (P < .05). Neither drug significantly affected plasma concentrations of AM. In summary, although fenofibrate showed superiority in raising HDL and reducing ET-1, atorvastatin was more effective in reaching lipid targets in FCHL so that it can be proposed as the first-line option in the management of this atherogenic hyperlipidemia. 相似文献
994.
Although the evolutionary theories of aging are quite well established, our knowledge about how we age is still very limited. The abundance and heterogeneity of available mechanistic theories of aging implicitly suggest that this phenomenon is overly complex and unlikely to be explained by a single pathway. Moreover, although aging remains a unique process, it is characterized by heterogeneous manifestations, not only determining inter-individual variations, but even intra-individual diversities. Such heterogeneity renders the inner nature of the aging process of difficult evaluation in older persons due to the potential biases introduced by multiple age-related social, biological, and clinical factors (and responsible for the evidence-based issue in geriatrics). Moving from the difficulties in translating anti-aging preclinical interventions into clinical trials, an alternative approach is illustrated. We encourage moving to a holistic evaluation of aging by adopting specific and consequent modifications in the design and conduction of clinical research. Such approach is today commonly applied in the clinical setting where the complexity of older patients often requires multidimensional interventions to adequately target the geriatric syndromes. Consistently, interventions targeting the aging process may result ineffective if too focused on a single underlying causal mechanism and/or failing to capture the complexity of the phenomenon. In this context, frailty (a geriatric syndrome characterized by age-related declines occurring across multiple physiologic systems) may indeed represent a clinically relevant threshold throughout the continuum of the aging process and a promising benchmark to test multidomain interventions against age-related conditions. 相似文献
995.
It has been recently shown that in vitro platelet aggregation is inhibited when platelet concentration in platelet-rich plasma (PRP) is “normalized” by the addition of platelet-poor plasma (PPP). In this study we tested the hypothesis that the large amount of PPP required to “normalize” PRP in patients with thrombocytosis may result in falsely defective platelet function. To this end, we evaluated platelet aggregation in PRP samples “normalized” with either PPP or buffer in 16 patients with high platelet counts induced by myeloproliferative disorders. Comparison with the results obtained in healthy subjects demonstrated that patients had reduced platelet responses to ADP or collagen in PRP/PPP samples, but normal responses in PRP/buffer. By contrast, the majority of patients had severely defective platelet response to epinephrine independently from the methodological approach. We suggest that the reduced in vitro platelet aggregation previously described in patients with myeloproliferative disorders and thrombocytosis partially derived from a laboratory artefact. 相似文献
996.
Dr. Giampiero La Rocca Antonino Di Stefano Ermanno Eleuteri Rita Anzalone Francesca Magno Simona Corrao Tiziana Loria Anna Martorana Claudio Di Gangi Marilena Colombo Fabrizio Sansone Francesco Patanè Felicia Farina Mauro Rinaldi Francesco Cappello Pantaleo Giannuzzi Giovanni Zummo 《Basic research in cardiology》2009,104(3):307-320
Increased oxidative stress has been implicated in the pathogenesis of a number of cardiovascular diseases. Recent findings
suggest that myeloperoxidase (MPO) may play a key role in the initiation and maintenance of chronic heart failure (CHF) by
contributing to the depletion of the intracellular reservoir of nitric oxide (NO). NO consumption through MPO activity may
lead to protein chlorination or nitration, leading to tissue damage. Primary cultures of human endocardial endothelial cells
(EEC) obtained at heart transplantation of patients with CHF and human umbilical vein endothelial cells (HUVEC) were subjected
to oxidative stress by incubation with hydrogen peroxide at non lethal (60 μM) dose for different exposure times (3 and 6 h).
Treated and control cells were tested by immunohistochemistry and RT-PCR for MPO and 3-chlorotyrosine expression. Both endothelial
cell types expressed myeloperoxidase following oxidative stress, with higher levels in EEC. Moreover, 3-chlorotyrosine accumulation
in treated cells alone indicated the presence of MPO-derived hypochlorous acid. Immunohistochemistry on sections from post-infarcted
heart confirmed in vivo the endothelial positivity to MPO, 3-chlorotyrosine and, to a minor extent, nitrotyrosine. Immunohistochemical
observations were confirmed by detection of MPO mRNA in both stimulated EEC and HUVEC cells. This study demonstrates for the
first time that EEC can express MPO after oxidative stress, both in vitro and in vivo, followed by accumulation of 3-chlorotyrosine,
an end product of oxidative stress. Deregulation of endothelial functions may contribute to the development of a number of
cardiovascular diseases, including CHF. The results also highlight the notion that endothelium is not only a target but also
a key player in oxidative-driven cardiovascular stress.
Electronic supplementary material The online version of this article (doi: ) contains supplementary material, which is available to authorized users.
G. La Rocca and A. Di Stefano contributed equally to the current work.
Returned for 1. Revision: 7 January 2008 1. Revision received: 18 June 2008
Returned for 2. Revision: 17 July 2008 2. Revision received: 17 October 2008 相似文献
997.
Barresi V Grosso M Vitarelli E Tuccari G Barresi G 《Diseases of the colon and rectum》2007,50(10):1576-1584
Purpose It has been extensively documented that the cyclooxygenase inducible form and 15-lipoxygenase are implicated in colorectal
carcinogenesis. Nonetheless, the role of other enzymes involved in the arachidonic acid metabolism, such as 5-lipoxygenase,
in colorectal neoplasms has not been fully ascertained. This study was designed to evaluate 5-lipoxygenase expression in sporadic
colorectal adenocarcinomas by using immunohistochemistry and to analyze its potential correlations with clinicopathologic
parameters and with cyclooxygenase-2 expression.
Methods Expression of 5-lipoxygenase and cyclooxygenase-2 were evaluated by immunohistochemistry in 50 surgically resected sporadic
colorectal adenocarcinomas (28 male and 22 female patients age range, 47–88 (mean age, 69 ± 8) years). The chi-squared and
Spearman correlation tests were used to analyze correlations with clinicopathologic characteristics and to evaluate any relationships
between expression of the two enzymes. P values <0.05 were considered statistically significant.
Results 5-Lipooxygenase and cyclooxygenase-2 immunostaining was found in the cytoplasm of neoplastic cells in 41 (82 percent) and
in 43 cases (86 percent), respectively. Spearman correlation test demonstrated a positive correlation in the expression of
the two enzymes. A statistically significant correlation also was observed between 5-lipoxygenase expression and tumor stage
and lymph node metastasis, whereas no significant correlations emerged regarding cyclooxygenase-2 expression and clinicopathologic
parameters.
Conclusions Our study demonstrates that 5-lipoxygenase is expressed in colorectal adenocarcinomas in association with cyclooxygenase-2
expression. Moreover, an elevated expression of this enzyme seems to be significantly correlated with tumor aggressiveness.
Further studies would clarify the need for target therapies inhibiting both metabolic pathways in such tumors.
Supported by the grants from the University of Messina, Messina, Italy.
Presented at the meeting of the Italian Society of Anatomic Pathology and Diagnostic Cytopathology (SIAPEC), Venice, Italy,
October 4 to 5, 2006. 相似文献
998.
Prevalence,severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes 下载免费PDF全文
Fabio Efficace Gianluca Gaidano Massimo Breccia Marianna Criscuolo Francesco Cottone Giovanni Caocci David Bowen Michael Lübbert Emanuele Angelucci Reinhard Stauder Dominik Selleslag Uwe Platzbecker Grazia Sanpaolo Anna Jonasova Francesco Buccisano Giorgina Specchia Giuseppe A. Palumbo Pasquale Niscola Chonghua Wan Huiyong Zhang Susanna Fenu Virginia Klimek Odile Beyne‐Rauzy Khanh Nguyen Franco Mandelli 《British journal of haematology》2015,168(3):361-370
The primary objective of this study was to investigate factors associated with fatigue severity in newly diagnosed patients with higher‐risk myelodysplastic syndromes (MDS). The secondary objectives were to assess symptom prevalence and to examine the relationships between fatigue, quality of life (QoL) and overall symptom burden in these patients. The analyses were conducted in 280 higher‐risk MDS patients. Pre‐treatment patient‐reported fatigue was evaluated with the Functional Assessment of Chronic Illness Therapy (FACIT)‐Fatigue scale and QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire‐Core 30 (EORTC QLQ‐C30). Female gender (P = 0·018), poor performance status (i.e., ECOG of 2–4) (P < 0·001) and lower levels of haemoglobin (Hb) (P = 0·026) were independently associated with higher fatigue severity. The three most prevalent symptoms were as follows: fatigue (92%), dyspnoea (63%) and pain (55%). Patients with higher levels of fatigue also had greater overall symptom burdens. The mean global QoL scores of patients with the highest versus those with the lowest levels of fatigue were 29·2 [standard deviation (SD), 18·3] and 69·0 (SD, 18·8), respectively and this difference was four times the magnitude of a clinically meaningful difference. Patient‐reported fatigue severity revealed the effects of disease burden on overall QoL more accurately than did degree of anaemia. Special attention should be given to the female patients in the management of fatigue. 相似文献
999.
1000.
Guercio Giovanni Cudia Bianca Ricotta Calogero Bavetta Francesco Diana Giuseppe 《BMC geriatrics》2009,9(1):1-4
Falls remain a major public health problem, despite strong growth in the research evidence of effective single and multifactorial interventions, particularly in the community setting. A number of aspects of falls prevention require individual tailoring, despite limitations being reported regarding some of these, including questions being raised regarding the role of falls risk screening and falls risk assessment. Being able to personalise an individual's specific risk and risk factors, increase their understanding of what interventions are likely to be effective, and exploring options of choice and preference, can all impact upon whether or not an individual undertakes and sustains participation in one or more recommendations, which will ultimately influence outcomes. On all of these fronts, the individual patient receiving appropriate and targeted interventions that are meaningful, feasible and that they are motivated to implement, remains central to effective translation of falls prevention research evidence into practice. 相似文献